Dr Pepper Snapple Group (NYSE:DPS) had its price target boosted by Wells Fargo & Co from $98.00 to $112.00 in a report issued on Thursday, January 4th. The firm presently has an “outperform” rating on the stock. Wells Fargo & Co’s price target would suggest a potential downside of 4.31% from the company’s current price.

Other equities analysts have also issued reports about the stock. BMO Capital Markets restated a “buy” rating and set a $105.00 target price on shares of Dr Pepper Snapple Group in a research report on Wednesday, September 6th. Deutsche Bank initiated coverage on shares of Dr Pepper Snapple Group in a research report on Wednesday, December 13th. They set a “buy” rating and a $104.00 target price on the stock. Jefferies Group lowered their target price on shares of Dr Pepper Snapple Group from $112.00 to $111.00 and set a “buy” rating on the stock in a research report on Friday, October 13th. Stifel Nicolaus lowered their target price on shares of Dr Pepper Snapple Group from $114.00 to $106.00 and set a “buy” rating on the stock in a research report on Thursday, October 26th. Finally, Royal Bank of Canada restated a “hold” rating and set a $91.00 target price on shares of Dr Pepper Snapple Group in a research report on Wednesday, October 25th. Eleven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $106.79.

Dr Pepper Snapple Group (DPS) opened at $117.04 on Thursday. The company has a current ratio of 0.93, a quick ratio of 0.74 and a debt-to-equity ratio of 2.07. The stock has a market cap of $17,268.79, a P/E ratio of 29.32, a PEG ratio of 2.05 and a beta of 0.59. Dr Pepper Snapple Group has a 1 year low of $83.23 and a 1 year high of $126.65.

A number of large investors have recently bought and sold shares of DPS. Acrospire Investment Management LLC lifted its holdings in Dr Pepper Snapple Group by 100.0% in the second quarter. Acrospire Investment Management LLC now owns 1,200 shares of the company’s stock valued at $109,000 after acquiring an additional 600 shares during the period. Amica Retiree Medical Trust acquired a new stake in Dr Pepper Snapple Group in the third quarter valued at $110,000. Sun Life Financial INC lifted its holdings in Dr Pepper Snapple Group by 13,360.0% in the second quarter. Sun Life Financial INC now owns 1,346 shares of the company’s stock valued at $123,000 after acquiring an additional 1,336 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in Dr Pepper Snapple Group by 6.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,926 shares of the company’s stock valued at $175,000 after acquiring an additional 120 shares during the period. Finally, Seven Eight Capital LP acquired a new stake in Dr Pepper Snapple Group in the second quarter valued at $182,000. Hedge funds and other institutional investors own 90.13% of the company’s stock.

WARNING: This piece was reported by Marea Informative and is the sole property of of Marea Informative. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.mareainformativa.com/wells-fargo-co-raises-dr-pepper-snapple-group-dps-price-target-to-112-00-updated-updated-updated/126599/.

Dr Pepper Snapple Group Company Profile

Dr Pepper Snapple Group, Inc is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The Company offers a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

Analyst Recommendations for Dr Pepper Snapple Group (NYSE:DPS)

Receive News & Ratings for Dr Pepper Snapple Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group and related companies with MarketBeat.com's FREE daily email newsletter.